Total Payments
$627.55
2022 Payments
$13.80
Companies
12
Transactions
25
Medicare Patients
396
Medicare Billing
$88,262
Payment Breakdown by Category
Food & Beverage$553.29 (88.2%)
Education$74.26 (11.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $553.29 | 23 | 88.2% |
| Education | $74.26 | 2 | 11.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $259.22 | 6 | $0 (2018) |
| Lilly USA, LLC | $90.27 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.58 | 4 | $0 (2020) |
| ABBVIE INC. | $52.70 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $42.91 | 3 | $0 (2018) |
| Lundbeck LLC | $26.64 | 2 | $0 (2020) |
| Alkermes, Inc. | $24.80 | 1 | $0 (2017) |
| Daiichi Sankyo Inc. | $24.29 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.78 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $13.63 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.80 | 1 | ABBVIE INC. ($13.80) |
| 2020 | $111.68 | 7 | AbbVie Inc. ($38.90) |
| 2019 | $70.96 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($35.02) |
| 2018 | $378.12 | 9 | Allergan Inc. ($259.22) |
| 2017 | $52.99 | 3 | Alkermes, Inc. ($24.80) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/18/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/04/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Respiratory | ||||||
| 01/23/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Cardiology | ||||||
| 01/09/2020 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: NEUROLOGY | ||||||
| 01/02/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/21/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Anemia | ||||||
| 11/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/23/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $90.27 | General |
| 11/13/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $87.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: PSYCHIATRY | ||||||
| 05/29/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $59.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $80.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $14.28 | General |
| Category: NEPHROLOGY | ||||||
| 04/28/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: CNS | ||||||
| 03/16/2017 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 98 | 211 | $87,666 | $23,684 |
| 2022 | 3 | 109 | 186 | $77,919 | $20,504 |
| 2021 | 2 | 73 | 190 | $69,674 | $19,533 |
| 2020 | 3 | 116 | 268 | $81,370 | $24,542 |
Total Patients
396
Total Services
855
Medicare Billing
$88,262
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 79 | $36,903 | $9,817 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 104 | $34,790 | $9,650 | 27.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $15,973 | $4,217 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 65 | $30,363 | $8,799 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 91 | $30,441 | $7,068 | 23.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $17,114 | $4,636 | 27.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 160 | $52,634 | $14,564 | 27.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 30 | 30 | $17,040 | $4,969 | 29.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 204 | $51,751 | $16,182 | 31.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 50 | 50 | $24,834 | $7,212 | 29.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 14 | $4,785 | $1,147 | 24.0% |
About Dr. Gary Levinson, M.D
Dr. Gary Levinson, M.D is a Psychiatry healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841228228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Levinson, M.D has received a total of $627.55 in payments from pharmaceutical and medical device companies, with $13.80 received in 2022. These payments were reported across 25 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($553.29).
As a Medicare-enrolled provider, Levinson has provided services to 396 Medicare beneficiaries, totaling 855 services with total Medicare billing of $88,262. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Bend, OR
- Active Since 06/28/2006
- Last Updated 09/16/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1841228228
Products in Payments
- VRAYLAR (Drug) $273.02
- CREON (Drug) $38.90
- Vyvanse (Drug) $35.02
- ABILIFY MAINTENA (Drug) $28.63
- Aristada 441 mg (Drug) $24.80
- INJECTAFER (Drug) $24.29
- VYVANSE (Drug) $20.56
- XIFAXAN (Drug) $14.78
- SAMSCA (Drug) $14.28
- TRINTELLIX (Drug) $13.91
- SYMBICORT (Drug) $13.63
- NORTHERA (Drug) $12.73
- Lucemyra/Lofexidine (Drug) $11.65
- Repatha (Biological) $11.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bend
Donald Anderson, M.d, M.D
Psychiatry — Payments: $805.03
Psychiatry $805.03
W Campbell, Md, MD
Psychiatry — Payments: $695.60
Psychiatry $695.60
Dr. Anjula Ceesay, Do, DO
Psychiatry — Payments: $635.62
Psychiatry $635.62
Amit Bhatia, Md, MD
Psychiatry — Payments: $345.22
Psychiatry $345.22
Joseph Barrett, Md, MD
Psychiatry — Payments: $206.45
Psychiatry $206.45
Dr. Danielle Hafner, Md, MD
Psychiatry — Payments: $175.00
Psychiatry $175.00